Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment-Past, Present, and Future Aspects.
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.
Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.
A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures.
Early accurate diagnosis crucial in multiple sclerosis.
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
Glial Cell Development and Function in Zebrafish.
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
Accelerometry Reveals Differences in Gait Variability Between Patients with Multiple Sclerosis and Healthy Controls.
A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease.
ZOCOR (simvastatin) Tablets
The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis.
Clinical and pathological features of acute optic neuritis in Chinese patients.
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations.
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis.
Deleterious versus protective autoimmunity in multiple sclerosis.
Autophagy in immunity: Implications in etiology of autoimmune/autoinflammatory diseases.
Multiple sclerosis: Month of birth effect in MS-fact or artefact?
Multiple Sclerosis: Does Nogo Play a Role?
Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
IL-17: A new actor in IFN-driven systemic autoimmune diseases.
Urinary catheterization may not adversely impact quality of life in multiple sclerosis patients.
Therapeutic Potential of Fecal Microbiota Transplantation.
Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.
Pages
« first
‹ previous
…
252
253
254
255
256
257
258
259
260
…
next ›
last »